Antares Pharma Inc (NASDAQ:ATRS)

Delayed Data
As of Feb 27
 -0.04 / -1.51%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +53.26% increase from the last price of 2.61.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.00%
Growthannually -46.88%


Growthquarterly 22.41%
Growthannually 26.77%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account